SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001078782-12-001965
Filing Date
2012-08-10
Accepted
2012-08-10 15:24:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f13d080912_sc13d.htm SC 13D 20114
  Complete submission text file 0001078782-12-001965.txt   21823
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83793 | Film No.: 121024405
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019
Business Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019 8584054448
DERMASTAR INTERNATIONAL, LLC (Filed by) CIK: 0001539513 (see all company filings)

IRS No.: 452840324 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D